Find information on thousands of medical conditions and prescription drugs.

Ticarcillin

Ticarcillin, also known as Timentin, is a Beta-lactam antibiotic similar to penicillin. It is often used as an injectable antibiotic for the treatment of gram negative bacteria, and is especially effective against Pseudomonas aeruginosa. Its antibiotic properties arise from its ability to prevent cross-linking of peptidoglycan during cell wall synthesis when the bacteria tries to divide, causing death. It will not treat viruses, including the flu. Because it is similar in structure to penicillin, it should not be used by anyone with allergies to any penicillin-related antibiotic. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Many bacteria have developed a resistance to this antibiotic by producing beta-lactamase, which inactivates it. Therefore, all modern ticarcillin includes clavulanic acid, an inbibitor of these enzymes.

In molecular biology, ticarcillin is used to as an alternative to ampicillin to test the uptake of marker genes into bacteria. It prevents the appearance of satellite colonies that occur when ampicillin breaks down in the media. It is also used in plant molecular biology to kill agrobacterium, which is used to deliver genes to plant cells.

Chemically, ticarcillin is C15H16N2O6S2 (CAS number 34787-01-4). It is provided as a white or pale yellow powder. It is highly soluble in water, but should only be dissolved immediately prior to use to prevent degradation.

Read more at Wikipedia.org


[List your site here Free!]


Vibrio metschnikovii pneumonia
From Emerging Infectious Diseases, 10/1/05 by Frederic Wallet

To the Editor: Vibrio metschnikovii is a gram-negative, oxidase-negative bacillus. This species was isolated in 1981 from blood culture of an 82-year-old diabetic woman with cholecystitis (1). It was previously isolated from river water, clams, oysters (2), fish (3), and birds that died of a choleralike illness (4). We report isolation of V. metschnikovii in bronchial aspirate from a patient with pneumonia.

A 63-year-old man was admitted to the intensive care unit (ICU) of A. Calmette hospital in Lille, France, for acute respiratory failure related to community-acquired pneumonia. The patient had a history of chronic obstructive pulmonary disease with a forced expiratory volume of 820 mL in 1 s (32% of predictive value); he was treated with oral salmeterol, terbutaline, and prednisolone (40 mg/day). He was HIV negative. On ICU admission, he had the following values: respiratory rate 30/min, temperature 39[degrees]C, pulse rate 140/min, blood pressure 140/90 mm Hg, Glasgow coma score 15, leukocyte count 13.7 x [10.sup.9]/L, hemoglobin level 10.2 g/dL, procalcitonin level 22 ng/mL, and C-reactive protein level 73 mg/L. A chest radiograph showed diffuse bilateral infiltrates. Analysis of arterial blood gases with 6L of oxygen/min showed respiratory acidosis: pH 7.30, pC[O.sub.2] 59 mm Hg, p[O.sub.2] 78 mm Hg, HC[O.sub.3] 23 mmol/L, [O.sub.2]saturation 94%. Other laboratory test results were normal. After noninvasive ventilation failed, the patient was immediately intubated and mechanically ventilated.

Blood cultures and bronchial aspirate samples were obtained before initiating treatment with antimicrobial drugs. The patient was treated with amoxicillin/clavulanic acid and ciprofloxacin. Blood cultures showed negative results. Microscopic examination of the bronchial aspirate showed no squamous epithelial cells, a few gram-negative bacilli, leukocytes, and many ciliated bronchial cells. The presence of ciliated cells was the best indicator that secretions originated from the lower respiratory tract. A urinary antigenic test result for Legionella spp. was negative. Quantitative culture of the bronchial aspirate on bromocresol purple agar, blood agar (grown in an atmosphere of 5% C[O.sub.2]), and chocolate agar plates yielded V. metschnikovii ([10.sup.7] CFU/mL) and nonhemolytic streptococci ([10.sup.5] CFU/mL) as the oropharyngeal flora. These streptococci (gram-positive, catalase-negative) were not considered to be the pathogenic agent.

The strain of V. metschnikovii isolated was a gram-negative, curved rod. This facultative aeroanaerobic bacillus formed opaque colonies (diameter 3 mm) on blood agar in 24 h and showed complete hemolysis. It was catalase positive, oxidase negative, and did not reduce nitrate to nitrite. This strain was identified as V. metschnikovii with an ID GBN Vitek 2 card (bioMerieux, Marcy l'Etoile, France) (acceptable T identification index 0.22). Confirmation was done with a Microseq 500 16S ribosomal DNA bacterial kit (PE Applied Biosystems, Foster City, CA, USA). A 475-bp fragment was sequenced in an automated sequencer (360 ABI Prism, PE Applied Biosystems). The fragment was compared with National Center for Biotechnology Information (Bethesda, MD, USA) GenBank entries and showed 99% homology with V. metschnikovii (GenBank accession no. X74712.1). In vitro susceptibility testing with the AST-N032 Vitek 2 card (bioMerieux) showed that the organism was resistant to ampicillin, ticarcillin, piperacillin, and aminoglycosides.

The patient was successfully extubated. He was transferred to a pneumology ward on day 9 and discharged on day 15. Antimicrobial treatment was stopped on day 10.

Most nonhuman strains of V. metschnikovii are usually found in aquatic habitats (e.g., lakes and marine waters). Human clinical infections with this bacterium are rare; however, cases of epidemic diarrhea caused by V. metschnikovii have been reported (5,6). Contamination by water or fish was not always demonstrated in these cases, but an orofecal source is possible. In coproculture, this microorganism is probably not diagnosed: it was initially identified as normal aerobic flora because it was oxidase negative.

The first case of septicemia with If. metschnikovii was reported in 1981 in a patient with peritonitis and an inflamed gallbladder (1). Three other patients with similar septicemia, all >70 years of age, were described (7,8); 2 had polymicrobial results in blood cultures. V. metschnikovii was also found in a mucocutaneous site (wound infection) after saphenectomy in swab samples of the wound site (9).

The patient in our study denied contact with lake or sea water, and he had not eaten any seafood. He was a retired carpenter without contact with domestic or wild animals and did not recall an episode of diarrhea before his hospitalization. The source of contamination that caused his acute respiratory failure was not identified.

Miyake et al. showed that V. metschnikovii produces a cytolysin with hemolytic properties (10). This finding might explain the invasive process of this bacterium, which resulted in pulmonary lesions in a patient with respiratory deficiency. As far as we know, this is the first case of pneumonia caused by V. metschnikovii.

References

(l.) Jean-Jacques W, Rajashekaraiah KR, Farmer JJ, Hickman FW, Morris JG, Kallick CA. Vibrio metschnikovii bacteremia in a patient with cholecystitis. J Clin Microbiol. 1981;14:711-2.

(2.) Lee JV, Donovan TJ, Furniss AL. Characterization, taxonomy, and emended description of Vibrio metschnikovii. Int J Syst Bacteriol. 1978;28:99-111.

(3.) Hansen W, Pohl P, Seynave D, Bughin J, Yourassowski E. Isolements de Vibrio metschnikovii en Belgique. Ann Med Vet. 1989;133:343-6.

(4.) Farmer JJ III, Hickman-Brenner FW, Farming GR, Gordon CM, Brenner DJ. Characterization of Vibrio metschnikovii and Vibrio gazogenes by DNA-DNA hybridization and phenotype. J Clin Microbiol. 1988;26:1993-2000.

(5.) Dalsgaard A, Alarcon A, Lanata CF, Jensen T, Hansen HJ, Delgado F, et al. Clinical manifestations and molecular epidemiology of five cases of diarrhoea in children associated with Vibrio metschnikovii in Arequipa, Peru. J Med Microbiol. 1996;45:494-500.

(6.) Magalhaes V, Branco A, de Andrade Lima R, Magalhaes M. Vibrio metschnikovii among diarrheal patients during cholera epidemic in Recife, Brazil. Rev Inst Med Trop Sao Paulo. 1996;38:1-3.

(7.) Hansen W, Freney J, Benyagoub H, Letouzey MN, Gigi J, Wauters G. Severe human infections caused by Vibrio metschnikovii. J Clin Microbiol. 1993;31:2529-30.

(8.) Hardardottir H, Vikenes K, Digranes A, Lassen J, Halstensen A. Mixed bacteremia with Vibrio metschnikovii in a 83-year-old female patient. Scand J Infect Dis. 1994;26:493-4.

(9.) Linde HJ, Kobuch R, Jayasinghe S, Reischl U, Lehn N, Kaulfuss S, et al. Vibrio metschnikovii, a rare cause of wound infection. J Clin Microbiol. 2004;42:4909-11.

(10.) Miyake M, Honda T, Miwatani T. Purification and characterization of Vibrio metschnikovii cytolysin. Infect Immun. 1988;56:954-60.

Frederic Wallet, * Mickael Tachon, * Saad Nseir, * Rene J. Courcol, * and Micheline Roussel-Delvallez *

* Lille University Medical Center, Lille, France

Address for correspondence: Frederic Wallet, Laboratoire de Bacteriologie-Hygiene, Boulevard du Pr Leclercq, 59037 Lille Cedex, France; fax: 33-3-20-44-48-95; email: fwallet@chru-lille, fr

COPYRIGHT 2005 U.S. National Center for Infectious Diseases
COPYRIGHT 2005 Gale Group

Return to Ticarcillin
Home Contact Resources Exchange Links ebay